|
|
||||||||
AJP - Heart and Circulatory Physiology, Vol 266, Issue 6 2320-H2326, Copyright © 1994 by American Physiological Society
ARTICLES |
C. J. Buzzard, S. L. Pfister, P. V. Halushka and W. B. Campbell
Department of Pharmacology, University of Texas Southwestern Medical Center, Dallas 75235.
In rabbit pulmonary artery, endothelium-dependent contractions to arachidonic acid and methacholine are mediated by thromboxane (Tx) A2. The TxA2 mimetics U-46619 and (1S-[1 alpha,2 beta(5Z),3 alpha(1E,3R*),4 alpha])-7-[3- [3-hydroxy-4-(4'-iodophenoxy)-1-butenyl]-7-oxabicyclo(2.2.1)hep tan-2-yl]- 5-heptenoic acid (I-BOP), norepinephrine, and endothelin produced endothelium-independent contractions. Arachidonic acid, methacholine, U-46619, and I-BOP failed to produce contractions in a subgroup of rabbits (25%). Nonresponder arteries contracted similarly to norepinephrine and endothelin as responder arteries. The affinity (Kd) and density (Bmax) of TxA2 receptors in crude pulmonary artery membranes were assessed via equilibrium binding studies using 125I-BOP. There was no difference in Kd between the two groups (0.49 +/- 0.17 vs. 0.32 +/- 0.14 nM, responder vs. nonresponder). There was a significant decrease in Bmax (123 +/- 21 vs. 28 +/- 11 fmol/mg protein, responder vs. nonresponder; P < 0.01) of receptors in the nonresponders. Nonresponder aortas also did not contract to U-46619 and exhibited a decrease in TxA2 receptors, indicating that the difference is not specific for the pulmonary artery. Nonresponder platelets aggregated to U-46619, suggesting that the platelet receptor is not altered. TxA2-receptor expression may be regulated in vivo. Nonresponder rabbits may provide a useful model for studying these receptors in vascular disease.
This article has been cited by other articles:
![]() |
M. J. Wacker, S. R. Best, L. M. Kosloski, C. J. Stachura, R. L. Smoot, C. B. Porter, and J. A. Orr Thromboxane A2-induced arrhythmias in the anesthetized rabbit Am J Physiol Heart Circ Physiol, April 1, 2006; 290(4): H1353 - H1361. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Wacker, H. L. Wilhelm, S. E. Gomez, E. Floor, and J. A. Orr Role of serotonin in thromboxane A2-induced coronary chemoreflex Am J Physiol Heart Circ Physiol, March 1, 2003; 284(3): H867 - H875. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. D. Minshall, D. Pavcnik, P. V. Halushka, and K. Hermsmeyer Progesterone regulation of vascular thromboxane A2 receptors in rhesus monkeys Am J Physiol Heart Circ Physiol, October 1, 2001; 281(4): H1498 - H1507. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Anwar, M. Schwab, L. Poston, and P. W. Nathanielsz Betamethasone-mediated vascular dysfunction and changes in hematological profile in the ovine fetus Am J Physiol Heart Circ Physiol, April 1, 1999; 276(4): H1137 - H1143. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. L. Pfister and W. B. Campbell Reduced Pulmonary Artery Vasoconstriction to Methacholine in Cholesterol-Fed Rabbits Hypertension, March 1, 1996; 27(3): 804 - 810. [Abstract] [Full Text] |
||||
![]() |
M. J. Wacker, R. N. Tehrani, R. L. Smoot, and J. A. Orr Thromboxane A2 mimetic evokes a bradycardia mediated by stimulation of cardiac vagal afferent nerves Am J Physiol Heart Circ Physiol, February 1, 2002; 282(2): H482 - H490. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |